Lars Jorgensen
businessmanMale0.0Global Dominance: 0.00%
Lars Jorgensen is the CEO of Novo Nordisk, a leading global healthcare company based in Denmark, known for its innovative diabetes and obesity treatments. Under his leadership, the company announced a significant investment of R$ 6.4 billion to expand its manufacturing facility in Montes Claros, Brazil, highlighting the strategic importance of the Brazilian market for Novo Nordisk.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Lars Jörgensen is the CEO of Novo Nordisk, who is set to leave his position before the end of his term.
«Linde ist ziemlich unangreifbar, fast so wie Apple»Neue Zürcher Zeitung·
Switzerland· 2025-05-18
Switzerland· 2025-05-18
Lars Jorgensen is the CEO of Novo Nordisk and announced a significant investment in Brazil.
Novo Nordisk investirá R$ 6,4 bilhões em fábrica mineira para produzir medicamentos como o OzempicO Estado de S. Paulo (Estadão)·
Liechtenstein· 2025-04-07
Liechtenstein· 2025-04-07
